Literature DB >> 30870249

A focus on vascular malformations.

M Luisa Iruela-Arispe1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30870249      PMCID: PMC6986810          DOI: 10.1097/MOH.0000000000000504

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


× No keyword cloud information.
  8 in total

Review 1.  Emerging molecular mechanisms of vascular dementia.

Authors:  Milagros C Romay; Camilo Toro; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 2.  Rapamycin and treatment of venous malformations.

Authors:  Emmanuel Seront; An Van Damme; Laurence M Boon; Miikka Vikkula
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 3.  Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia.

Authors:  Akiko Hata; Giorgio Lagna
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 4.  PIK3CA mutations in vascular malformations.

Authors:  Sandra D Castillo; Eulalia Baselga; Mariona Graupera
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 5.  CADASIL: new advances in basic science and clinical perspectives.

Authors:  Elisa A Ferrante; Cornelia D Cudrici; Manfred Boehm
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 6.  Bone morphogenetic protein and blood vessels: new insights into endothelial cell junction regulation.

Authors:  Victoria L Bautch
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 7.  A somatic missense mutation in GNAQ causes capillary malformation.

Authors:  Colette Bichsel; Joyce Bischoff
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 8.  Deregulated TGF-β/BMP Signaling in Vascular Malformations.

Authors:  Sara I Cunha; Peetra U Magnusson; Elisabetta Dejana; Maria Grazia Lampugnani
Journal:  Circ Res       Date:  2017-09-29       Impact factor: 17.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.